Order Article Reprints

Jirak P, Pistulli R, Lichtenauer M, Wernly B, Paar V, Motloch LJ, Rezar R, Jung C, Hoppe UC, Schulze PC, et al. Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls. Journal of Clinical Medicine. 2020; 9(4):1130. https://doi.org/10.3390/jcm9041130

Jirak, Peter, Rudin Pistulli, Michael Lichtenauer, Bernhard Wernly, Vera Paar, Lukas J. Motloch, Richard Rezar, Christian Jung, Uta C. Hoppe, P. Christian Schulze, and et al. 2020. "Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls" Journal of Clinical Medicine 9, no. 4: 1130. https://doi.org/10.3390/jcm9041130

Jirak, P., Pistulli, R., Lichtenauer, M., Wernly, B., Paar, V., Motloch, L. J., Rezar, R., Jung, C., Hoppe, U. C., Schulze, P. C., Kretzschmar, D., Braun-Dullaeus, R. C., & Bekfani, T. (2020). Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls. Journal of Clinical Medicine, 9(4), 1130. https://doi.org/10.3390/jcm9041130